| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0173-0892-01 | 0173-0892 | HUMAN PRESCRIPTION DRUG | Nucala | mepolizumab | INJECTION, SOLUTION | SUBCUTANEOUS | 20190606 | N/A | BLA | BLA761122 | GlaxoSmithKline LLC | MEPOLIZUMAB | 100 mg/mL | 1 SYRINGE in 1 CARTON (0173-0892-01) / 1 mL in 1 SYRINGE |
| 0173-0892-42 | 0173-0892 | HUMAN PRESCRIPTION DRUG | Nucala | mepolizumab | INJECTION, SOLUTION | SUBCUTANEOUS | 20190606 | N/A | BLA | BLA761122 | GlaxoSmithKline LLC | MEPOLIZUMAB | 100 mg/mL | 1 SYRINGE in 1 CARTON (0173-0892-42) / 1 mL in 1 SYRINGE |
| 0173-0892-61 | 0173-0892 | HUMAN PRESCRIPTION DRUG | Nucala | mepolizumab | INJECTION, SOLUTION | SUBCUTANEOUS | 20190606 | N/A | BLA | BLA761122 | GlaxoSmithKline LLC | MEPOLIZUMAB | 100 mg/mL | 1 SYRINGE in 1 CARTON (0173-0892-61) / 1 mL in 1 SYRINGE |
| 0173-0892-63 | 0173-0892 | HUMAN PRESCRIPTION DRUG | Nucala | mepolizumab | INJECTION, SOLUTION | SUBCUTANEOUS | 20190606 | N/A | BLA | BLA761122 | GlaxoSmithKline LLC | MEPOLIZUMAB | 100 mg/mL | 1 SYRINGE in 1 CARTON (0173-0892-63) / 1 mL in 1 SYRINGE |
| 0173-0904-42 | 0173-0904 | HUMAN PRESCRIPTION DRUG | Nucala | mepolizumab | INJECTION, SOLUTION | SUBCUTANEOUS | 20220122 | N/A | BLA | BLA761122 | GlaxoSmithKline LLC | MEPOLIZUMAB | 40 mg/.4mL | 1 SYRINGE in 1 CARTON (0173-0904-42) / .4 mL in 1 SYRINGE |